Murae Organisor share news and announcements

BSE: 542724Commercial Services & Supplies

Trading suspended since 25 May 2026

Last traded ₹0.19 on 25 Mar 2026

Murae Organisor share news and announcements

498 announcements, routine notices left out, newest first. Page 10 of 10.

Nov 2020
- 27 Nov · Shareholding for the Period Ended September 30, 2020
  Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
- 27 Nov · Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020
  Pursuant to requirement of Regulation 7(3) of the Securities and exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby certify that all .... (opens in a new tab)
- 27 Nov · Compliance Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2020
  Dear Sir / Madam, Pursuant to Regulation 40(10) of the Securities and exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith .... (opens in a new tab)
- 26 Nov · Statement Of Investor Complaints For The Quarter Ended September 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 11 Nov · Board meeting
  With reference to the captioned subject and pursuant to the Regulation 33 of SEBI (LODR) Regulation, 2015, the Board of Directors of the Company at its meeting held on today i.e. Wednesday, .... (opens in a new tab)
- 4 Nov · Board meeting
  Meeting on 11 Nov 2020: half yearly results
- 4 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve We hereby inform you .... (opens in a new tab)
Jul 2020
- 22 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 1 Jul · Results
  This has with reference to our submission, inadvertently the date of signing of Financial Statements by Auditor typed 22.06.2020 instead of 30.06.2020. We would like to bring this .... (opens in a new tab)
Jun 2020
- 30 Jun · Results
  We wish to inform that the Board of Directors of the Company at its meeting held on Tuesday, 30th June, 2020 has considered and approved the Audited Financial Results of the Company for .... (opens in a new tab)
- 24 Jun · Board meeting
  Meeting on 30 Jun 2020: audited results
- 24 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve Approval of Audited Financial .... (opens in a new tab)
May 2020
- 5 May · Intimation For Introduce Wide Range Of Hand Sanitizer In Liquid And Gel Base And Antiseptic Disinfectant Product Range To Fight Against COVID-19
  This is to inform you that the Company has started Production of wide range of Hand Sanitizer in liquid and Gel base and Antiseptic Disinfectant Product Range to fight against COVID-19 at its unit. (opens in a new tab)
- 4 May · Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended As On 31St March, 2020.
  Further, in compliance with the provision of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the certificate for the half .... (opens in a new tab)
Apr 2020
- 28 Apr · Compliance Certificate In Terms Of Regulation 40(9) Of SEBI (Listing And Obligations Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2020
  Find herewith attached Certificate under Regulation 40(9) of SEBI (Listing and Obligations Requirements) Regulations, 2015 for the half year ended on 31st March, 2020 issued by Bigshare .... (opens in a new tab)
- 25 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 24 Apr · Shareholding for the Period Ended March 31, 2020
  Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
- 2 Apr · Business
  Announcement under Regulation 30 (LODR)-Acquisition (opens in a new tab)
Jan 2020
- 20 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2019
Nov 2019
- 4 Nov · Results
  This is reference to our communication dated October 14, 2019 regarding the financial results, (Standalone) for half year ended September 30, 2019. The Board had approved the unaudited .... (opens in a new tab)
Oct 2019
- 22 Oct · Business
  Statement for Utilization of Public Issue Proceeds .... (opens in a new tab)
- 14 Oct · Compliance Certificate In Terms Of Regulation 40(9) Of SEBI (Listing And Obligations Requirements) Regulations, 2015 For The Half Year Ended On 30Th September, 2019
  Certificate under Regulation 40(9) of SEBI (Listing and Obligations Requirements) Regulations, 2015 for thehalf year ended on 30th September, 2019 issued by Bigshare Services Private Limited. .... (opens in a new tab)
- 14 Oct · Results
  Board of Directors at the meeting held today i.e. 14Th October, 2019, inter alia, transacted following' - 1. Approved Unaudited Financial Results of the Company for the half year .... (opens in a new tab)
- 14 Oct · Results
  Board of Directors at the meeting held today i.e. 14Th October, 2019, inter alia, transacted following' - 1. Approved Unaudited Financial Results of the Company for the half year .... (opens in a new tab)
- 10 Oct · Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended As On 30Th September, 2019
  We hereby,certify that all activities in relation to both physical and electronic share transfer facilities are maintained by the Company's Registrar and Share Transfer Agent, Viz., BIGSHARE .... (opens in a new tab)
- 10 Oct · Shareholding for the Period Ended September 30, 2019
  Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....
- 7 Oct · Board meeting
  Meeting on 14 Oct 2019: half yearly results
- 5 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve the unaudited financial .... (opens in a new tab)
- 4 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
- 28 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 28 Sep · Meeting
  Sub: Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 The 7th Annual General Meeting of Earum Pharmaceuticals Limited was held on Friday, .... (opens in a new tab)
- 27 Sep · Meeting
  Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above mentioned subject, we are hereby Submitting the proceedings .... (opens in a new tab)
- 12 Sep · Management
  1.Appointment of Mr.Bhavik Shantilal Patel as the Additional Director, Non-Executive- Independent Director his Appointment as Independent Director is subject to approval of shareholders .... (opens in a new tab)
- 10 Sep · Reg. 34 (1) Annual Report
  Enclosed is a copy of the Revised Annual Report being sent to the shareholders which contains the Notice of the Annual General .... (opens in a new tab)
- 7 Sep · Management
  1. We wish to inform you that Mr.Narendrakumar Gangaramdas Patel(DIN:07017438), Non Executive Director, of our Company,has submitted his letter of resignation dated September 7th ,2019 .... (opens in a new tab)
- 4 Sep · Reg. 34 (1) Annual Report
  Enclosed is a copy ofthe Annual Report being sent to the shareholders which contains the Notice of the Annual General Meeting .... (opens in a new tab)
Aug 2019
- 29 Aug · Meeting
  In reference with captioned subject,Regulation 42 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with section 91 of the Companies Act, 2013 that the share .... (opens in a new tab)
- 29 Aug · Board meeting
  In reference with our intimation in the said matte, the Board in their meeting held today i.e. August, 29 . 2019 at the corporate Office of the Company, have convened the 7th Annual General .... (opens in a new tab)
- 20 Aug · Board meeting
  Meeting on 29 Aug 2019: annual general meeting
- 20 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/08/2019 ,inter alia, to consider and approve In reference with above .... (opens in a new tab)
- 19 Aug · Business
  Earum Pharmaceuticals Ltd is pleased to announce that the Company has launch 15 New product of 'Dermacare', The supply of the same product would be starting from 26th of August,2019. (opens in a new tab)
Jul 2019
- 4 Jul · Listing of equity shares of Earum Pharmaceuticals Ltd
  Trading Members of the Exchange are hereby informed that effective from July 04, 2019, the equity shares of Earum Pharmaceuticals Ltd (Scrip Code: 542724) are listed and admitted to dealings ....